| Dr John C Munshower, DO | |
|
3855 W Chester Pike, Suite 300, Newtown Square, PA 19073-2304 | |
| (484) 427-8000 | |
| (484) 427-8020 |
| Full Name | Dr John C Munshower |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 33 Years |
| Location | 3855 W Chester Pike, Newtown Square, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427118074 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OS007741L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Main Line Health Home Care & Hospice - Home Health | Radnor, PA | Home health agency |
| Main Line Health Homecare & Hospice - Hospice | Radnor, PA | Hospice |
| Main Line Hospital Lankenau | Wynnewood, PA | Hospital |
| Riddle Memorial Hospital | Media, PA | Hospital |
| Bryn Mawr Hospital | Bryn mawr, PA | Hospital |
| Paoli Hospital | Paoli, PA | Hospital |
| Crozer Chester Medical Center | Upland, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Main Line Healthcare | 1951215201 | 894 |
News Archive
The Heart Failure Society of America (HFSA) 14th Annual Scientific Meeting convened Sunday, September 12, 2010 at the San Diego Convention Center in San Diego. This four-day meeting - a forum for heart failure specialists to present research findings and advances in treatment - will address emerging trends in research and new developments in the approach to treating patients with all stages of heart failure.
WHO is calling on the global health community to urgently address significant gaps in the prevention, diagnosis and treatment of malaria. Despite dramatic declines in malaria cases and deaths since 2000, more than half a million lives are still lost to this preventable disease each year.
Afferent Pharmaceuticals, a clinical-stage biopharmaceutical company developing first-in-class, small molecule compounds that target P2X3 receptors, today announced preclinical in vivo results demonstrating that an investigational P2X3 receptor antagonist reduced experimentally induced bladder hyperactivity.
In 2012, a group of UCLA researchers set out to mine thousands of electronic health records for a more accurate and less expensive way to identify people who have undiagnosed type 2 diabetes. The researchers got much more than they bargained for.
In a study that compared initial treatment strategies for low-risk prostate cancer among men 65 years old, active surveillance showed higher measures on quality of life compared to an initial treatment such as radical prostatectomy, although the optimal strategy was highly dependent on individual patient preferences for surveillance or treatment, according to a study in the December 1 issue of JAMA.
› Verified 2 days ago
| Entity Name | Main Line Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922077643 PECOS PAC ID: 1951215201 Enrollment ID: O20040308000373 |
News Archive
The Heart Failure Society of America (HFSA) 14th Annual Scientific Meeting convened Sunday, September 12, 2010 at the San Diego Convention Center in San Diego. This four-day meeting - a forum for heart failure specialists to present research findings and advances in treatment - will address emerging trends in research and new developments in the approach to treating patients with all stages of heart failure.
WHO is calling on the global health community to urgently address significant gaps in the prevention, diagnosis and treatment of malaria. Despite dramatic declines in malaria cases and deaths since 2000, more than half a million lives are still lost to this preventable disease each year.
Afferent Pharmaceuticals, a clinical-stage biopharmaceutical company developing first-in-class, small molecule compounds that target P2X3 receptors, today announced preclinical in vivo results demonstrating that an investigational P2X3 receptor antagonist reduced experimentally induced bladder hyperactivity.
In 2012, a group of UCLA researchers set out to mine thousands of electronic health records for a more accurate and less expensive way to identify people who have undiagnosed type 2 diabetes. The researchers got much more than they bargained for.
In a study that compared initial treatment strategies for low-risk prostate cancer among men 65 years old, active surveillance showed higher measures on quality of life compared to an initial treatment such as radical prostatectomy, although the optimal strategy was highly dependent on individual patient preferences for surveillance or treatment, according to a study in the December 1 issue of JAMA.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John C Munshower, DO 3855 W Chester Pike, Suite 300, Newtown Square, PA 19073-2304 Ph: (484) 427-8000 | Dr John C Munshower, DO 3855 W Chester Pike, Suite 300, Newtown Square, PA 19073-2304 Ph: (484) 427-8000 |
News Archive
The Heart Failure Society of America (HFSA) 14th Annual Scientific Meeting convened Sunday, September 12, 2010 at the San Diego Convention Center in San Diego. This four-day meeting - a forum for heart failure specialists to present research findings and advances in treatment - will address emerging trends in research and new developments in the approach to treating patients with all stages of heart failure.
WHO is calling on the global health community to urgently address significant gaps in the prevention, diagnosis and treatment of malaria. Despite dramatic declines in malaria cases and deaths since 2000, more than half a million lives are still lost to this preventable disease each year.
Afferent Pharmaceuticals, a clinical-stage biopharmaceutical company developing first-in-class, small molecule compounds that target P2X3 receptors, today announced preclinical in vivo results demonstrating that an investigational P2X3 receptor antagonist reduced experimentally induced bladder hyperactivity.
In 2012, a group of UCLA researchers set out to mine thousands of electronic health records for a more accurate and less expensive way to identify people who have undiagnosed type 2 diabetes. The researchers got much more than they bargained for.
In a study that compared initial treatment strategies for low-risk prostate cancer among men 65 years old, active surveillance showed higher measures on quality of life compared to an initial treatment such as radical prostatectomy, although the optimal strategy was highly dependent on individual patient preferences for surveillance or treatment, according to a study in the December 1 issue of JAMA.
› Verified 2 days ago
Allen Russell Harris, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3537 W Chester Pike, Newtown Square, PA 19073 Phone: 610-601-9177 Fax: 610-016-9168 | |
Jennifer Hwang, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3855 W Chester Pike Ste 300, Newtown Square, PA 19073 Phone: 484-427-8000 Fax: 484-427-8020 | |
David S. Fox, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3855 W Chester Pike, Suite 300 Main Line Health Center, Newtown Square, PA 19073 Phone: 484-427-8000 Fax: 484-427-8020 | |
David R. Jones, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 13 Saint Albans Circle, Suite C, Newtown Square, PA 19073 Phone: 610-853-2900 Fax: 610-853-2980 | |
Dr. Pat F Romano, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3855 W Chester Pike, Suite 300, Newtown Square, PA 19073 Phone: 484-427-8000 Fax: 484-427-8020 | |
Dr. Michael F Prime, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3855 W Chester Pike Ste 300, Newtown Square, PA 19073 Phone: 484-427-8000 Fax: 484-427-8020 | |
William D. Claypool, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4104 Meadow Ln, Newtown Square, PA 19073 Phone: 484-420-4300 |